Also trades as: CLBTW (NASDAQ) · $vol 1M

$11.93

-0.30 (-2.45%)

Weekly Expected Move ±5.1%

$11 $11 $12 $13 $13

NASDAQ · Technology · Software - Infrastructure · Tech Score Buy · Power 64 · $3.0B mcap · 126M float · 2.14% daily turnover · Short 41% of daily vol

Credit Risk of going bust: lower than 80% of companies Debt: 0.8% of company value Bonds: none of note held by US funds details ▾

If the stock fell to about $0.01 (down 99.9%), Cellebrite DI Ltd. would be worth roughly what it owes.
Total debt $23.2M against a stock market value of $3.00B.
Distance to default 9.60 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $5.7M (short-term plus half of long-term), stock volatility 63.7%; Altman Z'' 3.07. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue

$476M +18.6% ▲

5Y CAGR: +19.5%

Gross Profit

$401M +18.3% ▲

5Y CAGR: +20.6%

Operating Income

$66M +16.8% ▲

5Y CAGR: +48.5%

Net Income

$78M +127.7% ▲

5Y CAGR: +68.4%

EPS (Diluted)

$0.31 +123.0% ▲

5Y CAGR: +58.6%

EBITDA

$78M +16.0% ▲

5Y CAGR: +35.3%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$246M	$271M	$325M	$401M	$476M
YoY Growth	+26.3%	+9.9%	+20.1%	+23.4%	+18.6%
Cost of Revenue	$43M	$51M	$53M	$63M	$75M
Gross Profit	$204M	$220M	$272M	$339M	$401M
Gross Margin	82.7%	81.3%	83.6%	84.4%	84.2%
R&D Expenses	$66M	$81M	$84M	$98M	$114M
SG&A Expenses	$124M	$138M	$154M	$183M	$220M
Operating Expenses	$190M	$219M	$239M	$282M	$334M
Operating Income	$14M	$1M	$33M	$57M	$66M
Operating Margin	5.6%	0.4%	10.2%	14.2%	14.0%
Interest Expense	$153K	$149K	$0	$350M	$0
Income Before Tax	$82M	$121M	-$76M	-$276M	$91M
Tax Expense	$11M	-$45K	$6M	$7M	$12M
Net Income	$71M	$121M	-$81M	-$283M	$78M
Net Margin	29.0%	44.6%	-24.9%	-70.5%	16.5%
EPS (Diluted)	$0.44	$0.59	$-0.43	$-1.35	$0.31
EBITDA	$89M	$130M	-$65M	$68M	$78M
Shares Outstanding	162M	195M	190M	209M	250M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$107M	$109M	$108M	$113M	$126M	$129M	$128M	$131M
Cost of Revenue	$15M	$18M	$17M	$18M	$20M	$20M	$22M	$25M
Gross Profit	$91M	$91M	$90M	$96M	$106M	$109M	$106M	$106M
Gross Margin	85.5%	83.8%	83.7%	84.4%	83.9%	84.7%	82.5%	80.8%
R&D Expenses	$26M	$26M	$27M	$29M	$28M	$30M	$36M	$36M
SG&A Expenses	$46M	$50M	$51M	$53M	$59M	$58M	$61M	$62M
Operating Expenses	$72M	$76M	$78M	$81M	$87M	$88M	$97M	$98M
Operating Income	$19M	$16M	$12M	$14M	$19M	$21M	$9M	$8M
Operating Margin	18.2%	14.4%	11.4%	12.7%	15.1%	16.2%	7.1%	5.8%
Interest Expense	$224M	$0	$0	$0	$0	$0	$0	$0
Income Before Tax	-$205M	$20M	$19M	$21M	$24M	$26M	$14M	$11M
Tax Expense	$3M	$628K	$2M	$1M	$4M	$5M	$3M	$5M
Net Income	-$207M	$19M	$17M	$19M	$20M	$21M	$11M	$6M
Net Margin	-193.8%	17.7%	16.2%	17.2%	16.0%	16.5%	8.5%	4.9%
EPS (Diluted)	$-0.99	$0.08	$0.07	$0.08	$0.08	$0.08	$0.04	$0.03
EBITDA	$22M	$18M	$15M	$17M	$27M	$49M	$21M	$17M
Shares Outstanding	209M	247M	249M	249M	250M	252M	252M	253M

CLBT NASDAQ